News | Women's Health | October 04, 2019

The company celebrates recent portfolio expansion to address the entire continuum of breast cancer diagnosis and care

Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2

Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2 to mark the start of Breast Cancer Awareness Month.

Hologic has expanded its product portfolio significantly in recent months through insight-driven innovation and strategic acquisitions to address the entire continuum of breast cancer diagnosis and care. From tomosynthesis to ultrasound, to digital specimen radiography and stereotactic breast biopsy systems, to breast biopsy markers and surgical guidance systems — Hologic’s comprehensive suite of products is designed to meet the needs of radiologists, pathologists, breast surgeons and patients.

“As the world leader in mammography and a company focused on women’s health, we’re committed to early detection, more certain diagnoses, and accurate and compassionate treatment for women facing breast cancer,” said MacMillan. “We’re proud to recognize Breast Cancer Awareness Month by ringing the Nasdaq Opening Bell for the 14th year in a row, and we’re grateful to be joined by many of the dedicated employees whose passion fuels the work we do.”

Hologic’s participation in the Nasdaq opening bell ceremony was aired live at https://new.livestream.com/NASDAQ/live and with closed captioning on the Nasdaq MarketSite tower in Times Square. The video of the ceremony will be archived for one year on the Nasdaq site.

For more information: www.hologic.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
Subscribe Now